Hennion & Walsh Asset Management, Inc. Editas Medicine, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 226,756 shares of EDIT stock, worth $659,859. This represents 0.04% of its overall portfolio holdings.
Number of Shares
226,756
Previous 168,371
34.68%
Holding current value
$659,859
Previous $786,000
1.65%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding EDIT
# of Institutions
243Shares Held
58.9MCall Options Held
494KPut Options Held
417K-
Vanguard Group Inc Valley Forge, PA8.03MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.78MShares$22.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$17.5 Million0.92% of portfolio
-
State Street Corp Boston, MA4.59MShares$13.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.46MShares$7.16 Million0.01% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $200M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...